- Funding round supported by High-Tech Gründerfonds (HTGF), Brandenburg Kapital and several private investors, showing their continued commitment
- Funds to be mainly used to complete ongoing REMOVE study with CATUVAB®, extend clinical program,…
Reinforcement agreed with Livit, one of the leading patient care providers in the Netherlands
ProBioGen today announced that Innovent Biologics, Inc. (1801.HK) has signed a multi-product license for ProBioGen's GlymaxX technology.
Under this license agreement, Innovent receives non-exclusive rights to use the afucosylation technology…
- New funding from US and European-based investors, including Farallon Capital, Red River West and Bertelsmann Investments, follows a $90 million raise in May 2021. Schroders Capital acquires secondary shares through public and private vehicles
-…
Cell-based medicine has the potential to detect and counteract diseases long before symptoms become apparent. This comparatively young medical approach uses a large number of new technologies to achieve this. The Berlin Cell Hospital, which is newly…
From Berlin-Tempelhof to the whole world: TIB Molbiol employees developed the world’s first corona test. In the meantime, millions of people have been tested with the kits and the orders don’t stop coming in. Long-standing partner Roche recently…
Charité retains its longstanding position at the top of the rankings.
Glycotope to spin-out its Service Business to the newly formed FyoniBio GmbH
In the journal Science*, researchers from Charité – Universitätsmedizin Berlin and Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) present new findings on the immune response against the coronavirus SARS-CoV-2. Their study is based on…
Sanofi is now accepting submissions for the 2022 Sanofi Golden Ticket Competition!
Sanofi is a global sponsor of BioLabs, a premier shared laboratory space for life science and biotech startups to test new ideas and innovate. …
